跳至主要内容
临床试验/ISRCTN07355119
ISRCTN07355119已完成3 期

A randomised trial to evaluate whether treatment can be reduced without compromising effficacy in a low risk group of patients defined by a molecular minimal residual disease (MRD) technique; and to evaluate whether further post-remission intensification can improve outcome for a MRD-defined high risk group

niversity of Sheffield (UK)0 个研究点目标入组 2,500 人开始时间: 2003年8月18日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
2,500

研究概览

简要总结

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Children aged 1 - 18 years with ALL
  • As of 12/02/2010, young adults up to their 25th birthday are also eligible for this trial.

排除标准

  • 1. Mature B ALL
  • 2. Infant ALL (aged less than 1 year)
  • 3. Philadelphia positive ALL

研究者

发起方
niversity of Sheffield (UK)

相似试验